Skip to main content

Non-segmental Vitiligo clinical trials at UC Health

1 in progress, 0 open to eligible people

Showing trials for
  • Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

    Sorry, not currently recruiting here

    The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adolescent and adult participants with non-segmental vitiligo for whom total body involved vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).

    at UCSF

Last updated: